Evaluation has a role to play in all parts of the REACH Regulation. Not only is it the process by which dossiers are checked to ensure compliance with registration requirements, but it is also one of the processes by which substances may be identified as candidates for Restriction or Authorisation.
Substances are evaluated by Member States to establish whether their use poses a risk to human health or the environment, and whether these risks are sufficiently controlled by the measures identified in registration dossiers.
The general criteria which leads to a substance being selected for evaluation are listed in Article 44 of REACH, however the criteria were refined in 2011. As the process of substance evaluation is looking at risk, both hazard-related and exposure-related criteria are considered.
Identification of a substance meeting any of the above criteria does not automatically mean the substance will be subject to evaluation. Those substances recommended are ranked in order of priority with some being discounted due to the fact they are already subject to regulatory measures. Those that are going to be evaluated will be included in the Community Rolling Action Plan (CoRAP).
Testing proposals As part of a registration under the REACH Regulation, a registrant is required to submit a dossier containing information about the substance to ECHA. What information needs to be submitted and what tests should be conducted to obtain this information are listed in Annexes VII-X of the Regulation, ...
